What is Taysha Gene Therapies, Inc.'s net investment in lease?

Taysha Gene Therapies, Inc. (TSHA) reported net investment in lease of $9.16M in Q1 2026.

How has Taysha Gene Therapies, Inc.'s net investment in lease changed year-over-year?

Taysha Gene Therapies, Inc.'s net investment in lease increased by 13.3% year-over-year, from $8.08M to $9.16M.

What is the long-term trend for Taysha Gene Therapies, Inc.'s net investment in lease?

Over 3 years (2022 to 2025), Taysha Gene Therapies, Inc.'s net investment in lease has grown at a -4.8% compound annual growth rate (CAGR), from $10.94M to $9.44M.

Taysha Gene Therapies, Inc. TSHA Net Investment in Lease

Net Investment in Lease at other companies

Ionis PharmaceuticalsIONS

——

BiogenBIIB

——

Acadia PharmaceuticalsACAD

——

uniQureQURE

——

PrecigenPGEN

——

Stoke Therapeutics, Inc.STOK

——

Other financials

Income statement

See full

Revenue--100%

Operating income-$43.5M-103%

Net income-$42.4M-97.0%

EPS (diluted)-$0.12-50.0%

Balance sheet

See full

Cash & equivalents$276.6M+137%

Total debt$68.6M+11.2%

Total equity$211.9M+285%

Total assets$300.4M+117%

Cash flow

See full

Operating cash flow-$40.9M-85.6%

CapEx$24.0K-93.7%

Free cash flow-$40.9M-82.6%

Valuation

See full

Market cap$1.97B+351%

Enterprise value$1.76B+368%

P/S263.9×+203×

Profitability

See full

Operating margin-1,774.4%+1,437pp

Net margin-1,738.4%+1,407pp

FCF margin-1,503.6%+621pp

Returns & leverage

See full

Return on equity-97.3%-27.3pp

Debt / equity0.3×-0.8×

Current ratio14×+8.7×

Where this comes from

Reported directly by Taysha Gene Therapies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Taysha Gene Therapies, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Taysha Gene Therapies, Inc.'s net investment in lease?: Taysha Gene Therapies, Inc. (TSHA) reported net investment in lease of $9.16M in Q1 2026.
How has Taysha Gene Therapies, Inc.'s net investment in lease changed year-over-year?: Taysha Gene Therapies, Inc.'s net investment in lease increased by 13.3% year-over-year, from $8.08M to $9.16M.
What is the long-term trend for Taysha Gene Therapies, Inc.'s net investment in lease?: Over 3 years (2022 to 2025), Taysha Gene Therapies, Inc.'s net investment in lease has grown at a -4.8% compound annual growth rate (CAGR), from $10.94M to $9.44M.